Brief: Bergenbio Q3 EBIT NOK -28.1 Million
14/11/2023 06:00
Nov 14 (Reuters) - Bergenbio Q3 revenue NOK 0. * Q3 operating expenses NOK 28.1 million
Recent news on Oncoinvent ASA
See all newsBrief: Oncoinvent To Raise Up To NOK 140 Million In Private Placement
Brief: Oncoinvent H1 Operating Loss NOK 69 Mln
Brief: Oncoinvent Secures New Patent Expanding Protection For Radspherin
Brief: Oncoinvent's Shares To Be Consolidated In Ratio Of 100:1
Brief: Oncoinvent To Increase Share Capital In Connection With Settlement Of Underwriting Fee